<DOC>
	<DOCNO>NCT00736489</DOCNO>
	<brief_summary>The purpose study investigate pharmacodynamics single dos AZD3199 asthmatic patient .</brief_summary>
	<brief_title>Single-dose Crossover Study Investigate Pharmacodynamics AZD3199</brief_title>
	<detailed_description />
	<mesh_term>Airway Obstruction</mesh_term>
	<mesh_term>AZD-3199</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<criteria>Asthmatic patient prebronchodilatory FEV1 60 % predict normal 1.5 liter . Men postmenopausal woman 18 year age . Reversible airway obstruction response classical beta2agonist ( salbutamol ) Non/exsmokers Any clinically significant disease disorder asthma Any clinically relevant abnormal finding screen examination Treatment systemic glucocorticosteroids within past 30 day Inhaled corticosteroid use dose keep constant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Asthma</keyword>
	<keyword>airway obstruction</keyword>
	<keyword>beta2-agonist</keyword>
	<keyword>efficacy</keyword>
	<keyword>inhalation</keyword>
</DOC>